Voluntary Recall of Iverhart Max Chewelable Tablets
#1
Voluntary Recall of Iverhart Max Chewelable Tablets
Voluntary Recall of Iverhart Max Chewable Tablets
On Monday, March 26, 2012 Virbac AH, Inc. announced a voluntary recall of a single production lot of IVERHART MAX® Chewable Tablets.
Affected Product: IVERHART MAX Chewable Tablets, Lot #110482 (Large, 50.1 - 100 lbs)
The lot number is stamped on the side lid/flap of the box in a white text field and on the blister foil of the individual doses. Please note that this voluntary recall affects only this specific lot – no other products are affected by this recall.
Virbac, after promptly notifying the FDA, is coordinating with our distributor network to voluntarily recall the affected product. Letters have been sent directly to veterinary distributors instructing them to cease distribution of this identified lot and to advise veterinary clinics in receipt of the identified product to cease dispensing this affected lot.
It is important to note that prior to releasing the identified product lot for sale and distribution, numerous tests were performed and all test results were within specifications permitting the release of the product. After release, routine product testing has determined that the ivermectin (an active ingredient) has failed to meet our required stability specifications. Consequently, some dogs dosed with the identified lot may not be fully protected against heartworm disease.
If any dog receiving IVERHART MAX Tablets is found infected with heartworms, treatment can be administered and will be covered under the IVERHART product satisfaction guarantee.
.
On Monday, March 26, 2012 Virbac AH, Inc. announced a voluntary recall of a single production lot of IVERHART MAX® Chewable Tablets.
Affected Product: IVERHART MAX Chewable Tablets, Lot #110482 (Large, 50.1 - 100 lbs)
The lot number is stamped on the side lid/flap of the box in a white text field and on the blister foil of the individual doses. Please note that this voluntary recall affects only this specific lot – no other products are affected by this recall.
Virbac, after promptly notifying the FDA, is coordinating with our distributor network to voluntarily recall the affected product. Letters have been sent directly to veterinary distributors instructing them to cease distribution of this identified lot and to advise veterinary clinics in receipt of the identified product to cease dispensing this affected lot.
It is important to note that prior to releasing the identified product lot for sale and distribution, numerous tests were performed and all test results were within specifications permitting the release of the product. After release, routine product testing has determined that the ivermectin (an active ingredient) has failed to meet our required stability specifications. Consequently, some dogs dosed with the identified lot may not be fully protected against heartworm disease.
If any dog receiving IVERHART MAX Tablets is found infected with heartworms, treatment can be administered and will be covered under the IVERHART product satisfaction guarantee.
.
#2
Typical Buck
Join Date: Oct 2004
Location:
Posts: 860
"Many herding breed dogs have a genetic predisposition to adverse drug reactions involving over a dozen different drugs. The most serious adverse drug reactions involve several antiparasitic agents (ivermectin, milbemycin and related drugs), the antidiarrheal agent loperamide (Imodium), and several anticancer drugs (vincristine, doxorubicin, others)."
http://www.vetmed.wsu.edu/depts-VCPL/
http://www.vetmed.wsu.edu/depts-VCPL/
#3
Typical Buck
Join Date: Oct 2004
Location:
Posts: 860
"Rarely is a case of heartworm detected in Washington. While the
reason is not known exactly, it is likely that this state’s climate does not support an active population of mosquitoes long enough for the parasite to maintain its complex life cycle. There’s also no evidence there is any increase in new cases. Professor William J. Foreyt, a parasitologist at WSU’s College of Veterinary Medicine and a heartworm authority, has studied the subject for more than 30 years.
...
Dr. Foreyt has concluded a multi-year heartworm incidence survey
of harvested, free-ranging coyotes primarily from eastern Washington and the areas where an occasional case is reported in dogs. He examined more than 600 susceptible coyotes after death and found no heartworm.
Typically, Washington dogs with heartworm have relocated to the
state from known heartworm regions. Diagnosis has still been very
uncommon and occurs most often on or around military installations and communities with a migrant population."
Community Practice Newsletter, Summer '09
Washington State University College of Veterinary Medicine
http://www.vetmed.wsu.edu/ClientED/c...y_practice.asp
reason is not known exactly, it is likely that this state’s climate does not support an active population of mosquitoes long enough for the parasite to maintain its complex life cycle. There’s also no evidence there is any increase in new cases. Professor William J. Foreyt, a parasitologist at WSU’s College of Veterinary Medicine and a heartworm authority, has studied the subject for more than 30 years.
...
Dr. Foreyt has concluded a multi-year heartworm incidence survey
of harvested, free-ranging coyotes primarily from eastern Washington and the areas where an occasional case is reported in dogs. He examined more than 600 susceptible coyotes after death and found no heartworm.
Typically, Washington dogs with heartworm have relocated to the
state from known heartworm regions. Diagnosis has still been very
uncommon and occurs most often on or around military installations and communities with a migrant population."
Community Practice Newsletter, Summer '09
Washington State University College of Veterinary Medicine
http://www.vetmed.wsu.edu/ClientED/c...y_practice.asp